Asunto(s)
Linfocitos T CD4-Positivos , Linfocitos T CD8-positivos , Neoplasias del Oído , Linfoma Cutáneo de Células T , Neoplasias Cutáneas , Anciano , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/patología , Neoplasias del Oído/inmunología , Neoplasias del Oído/patología , Humanos , Linfoma Cutáneo de Células T/inmunología , Linfoma Cutáneo de Células T/patología , Masculino , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patologíaRESUMEN
Increased numbers of CD8+CD28neg. T cells have been detected in the peripheral blood of patients with several types of malignancies. However, the role of these cells in anticancer immunity are not yet clear and CD8+CD28neg. T cells are a controversially discussed subpopulation reported both as immunosuppressive and cytotoxic. In this study, we examined the T cell receptor (TCR) repertoire and complementarity-determining region 3 sequences of CD28neg. T cells in a melanoma patient with recurrent disease who achieved long-term disease-free status. As a result, the patient's oligoclonal CD8+CD28neg. T cell compartment holds TCRs that are public and specific for Melan-A as well as several public TCRs reported for common viral antigens. While over 80% of his CD8+CD28neg. T cells expressed a cytotoxicity marker, CD57, only 0.01% of CD8+ CD28neg. T cells were positive for Foxp3. In conclusion, our results demonstrate that besides virus-specific also tumor-associated self-antigen targeting T cells accumulate in the CD28neg. compartment of the immunological memory. Since the patient is in ongoing complete remission for more than 9 years, CD8+CD28neg. T cells with the Melan-A-specific TCR might contribute to antitumor immunity in this patient.
Asunto(s)
Linfocitos T CD8-positivos/inmunología , Regiones Determinantes de Complementariedad/genética , Neoplasias del Oído/inmunología , Melanoma/inmunología , Receptores de Antígenos de Linfocitos T/genética , Adulto , Antígenos CD28/metabolismo , Citotoxicidad Inmunológica , Neoplasias del Oído/cirugía , Humanos , Inmunidad Celular , Memoria Inmunológica , Antígeno MART-1/inmunología , Masculino , Márgenes de Escisión , Melanoma/cirugía , Recurrencia , Inducción de Remisión , Especificidad del Receptor de Antígeno de Linfocitos TRESUMEN
PURPOSE: To evaluate whether the combination of radiofrequency (RF) ablation and local injection of the immunostimulant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces systemic antitumor immunity. MATERIALS AND METHODS: Japanese White rabbits with lung and auricle VX2 tumors were randomized into three groups: control (n = 8; no treatment), RF ablation only (n = 8; RF ablation to the lung tumor), and RF ablation with local BCG injection into the lung tumor (n = 8). Treatments were performed 1 week after tumor implantation. Survival was evaluated with Kaplan-Meier method and log-rank test. Weekly mean volume and specific growth rate (SGR) of auricle tumors were calculated, and comparisons were made by Mann-Whitney test. RESULTS: Median survival of control, RF-only, and RF/BCG groups were 23, 41.5, and 103.5 days, respectively. Survival was significantly prolonged in the RF-only and RF/BCG groups compared with the control group (P = .034 and P =.003, respectively), but no significant difference was found between the RF-only and RF/BCG groups (P = .279). Only in the RF/BCG group was mean auricle tumor volume decreased 5 weeks after implantation. No significant difference in SGR was found between the control and RF-only groups (P = .959), but SGR in the RF/BCG group was significantly lower than in the control group (P = .005). CONCLUSIONS: The combination of RF ablation and local injection of BCG resulted in distant tumor suppression compared with the control group, whereas RF ablation alone did not produce this effect. Therefore, the combination of RF ablation and local injection of BCG may induce systemic antitumor immunity.
Asunto(s)
Vacuna BCG/administración & dosificación , Ablación por Catéter/métodos , Neoplasias del Oído/inmunología , Neoplasias del Oído/terapia , Neoplasias Pulmonares/inmunología , Neoplasias Pulmonares/terapia , Adyuvantes Inmunológicos/administración & dosificación , Animales , Antineoplásicos/administración & dosificación , Línea Celular Tumoral , Terapia Combinada/métodos , Neoplasias del Oído/diagnóstico , Femenino , Inmunización/métodos , Inyecciones Intralesiones , Conejos , Tasa de Supervivencia , Resultado del TratamientoAsunto(s)
Neoplasias del Oído/diagnóstico por imagen , Neoplasias del Oído/patología , Linfoma/diagnóstico por imagen , Linfoma/patología , Neoplasias Cutáneas/diagnóstico por imagen , Neoplasias Cutáneas/patología , Anciano , Linfocitos T CD8-positivos/inmunología , Neoplasias del Oído/inmunología , Humanos , Linfoma/inmunología , Masculino , Radiografía , Neoplasias Cutáneas/inmunología , Resultado del TratamientoAsunto(s)
Linfocitos T CD8-positivos/inmunología , Neoplasias del Oído/inmunología , Linfoma Cutáneo de Células T/inmunología , Neoplasias Cutáneas/inmunología , Antígenos CD8/análisis , Linfocitos T CD8-positivos/patología , Neoplasias del Oído/patología , Humanos , Inmunohistoquímica , Linfoma Cutáneo de Células T/patología , Masculino , Persona de Mediana Edad , Pronóstico , Neoplasias Cutáneas/patologíaRESUMEN
We present a case of squamous spindle cell carcinoma of the external auditory meatus in a 38-year-old man. The tumour was extended to the inner ear, the temporal bone, the middle cranial fossa and the meningo-cerebral tissue. The surgical intervention of temporo-occipital craniotomy removed most of the neoplasia. At pathologic examination, the tumour showed an undifferentiated spindle cell pattern. Immunohistochemistry with a large antibody panel found a weak positivity only to EMA. The diagnosis was made when the electron microscopy showed rare junctional structures and tonofilaments.
Asunto(s)
Carcinoma , Fosa Craneal Media , Neoplasias del Oído , Oído Externo , Oído Interno , Meninges , Hueso Temporal , Adulto , Anticuerpos Antineoplásicos/inmunología , Audiometría de Tonos Puros , Carcinoma/inmunología , Carcinoma/cirugía , Carcinoma/ultraestructura , Fosa Craneal Media/inmunología , Fosa Craneal Media/cirugía , Fosa Craneal Media/ultraestructura , Diagnóstico Diferencial , Neoplasias del Oído/inmunología , Neoplasias del Oído/cirugía , Neoplasias del Oído/ultraestructura , Oído Externo/inmunología , Oído Externo/cirugía , Oído Externo/ultraestructura , Oído Interno/inmunología , Oído Interno/cirugía , Oído Interno/ultraestructura , Parálisis Facial/diagnóstico , Humanos , Inmunohistoquímica , Masculino , Meninges/inmunología , Meninges/cirugía , Meninges/ultraestructura , Microscopía Electrónica , Invasividad Neoplásica/ultraestructura , Estadificación de Neoplasias , Procedimientos Quirúrgicos Otológicos/métodos , Hueso Temporal/inmunología , Hueso Temporal/cirugía , Hueso Temporal/ultraestructuraRESUMEN
OBJECTIVE: To establish primary vestibular schwannoma (VS) cultures that selectively favor the growth of schwannoma cells. BACKGROUND: The lack of a suitable in vitro model of human VS cells has directly limited the progress of research on tumorigenesis and therapy. The problems of establishing pure VS culture include control of fibroblast proliferation. Current efforts to extend VS cell life span using viral oncogenes, by conferring the ability to proliferate in vitro, will yield cells intrinsically different from in vivo VS tumors. Much more desirable is the ability to culture VS cells without cellular transformation. METHODS: Tumor specimens from 17 patients were processed for cell culture and grown at 37 degrees C with 5% CO2 and 100% humidity. Key modifications limiting fibroblast proliferation included using selective medium without L-valine, supplemented by Nu-Serum for at least a week; the use of cytosine arabinoside to kill contaminating fibroblasts; and using the Dulbecco modified medium, supplemented with brain-derived neurotrophic factor and 10% fetal calf serum after the initial serum-free period. RESULTS: Twelve of 17 VS were successfully cultured. The presence of schwannoma cells and the absence of fibroblasts were confirmed immunohistochemically using S100 and CD90 markers, respectively. Scanning and transmission electron microscopy demonstrated typical spindle-shaped cells and the presence of "fibrous long-spacing collagen." CONCLUSION: We describe a method for obtaining short-term, essentially fibroblast-free, primary VS cultures. Such pure VS cultures, retaining in vivo characteristics, are extremely useful as an in vitro model to study the pathobiology of schwannoma cells.
Asunto(s)
Neoplasias del Oído/ultraestructura , Neuroma Acústico/ultraestructura , Progresión de la Enfermedad , Neoplasias del Oído/inmunología , Humanos , Inmunohistoquímica , Técnicas In Vitro , Microscopía Electrónica de Transmisión , Neuroma Acústico/inmunologíaRESUMEN
We report a 74-year-old woman with primary CD5-positive diffuse large B-cell lymphoma (DLBCL) of the temporal bone. The patient was admitted because of a mass in the left external auditory canal. She was treated with eight courses of CEOP therapy (rituximab was added from the sixth course) followed by radiotherapy of 40 Gy, and complete remission was achieved. The occurrence of malignant lymphoma in the temporal bone, which is an extremely unusual site, may have depended on the peculiarity of CD5-positive DLBCL.
Asunto(s)
Neoplasias Óseas/patología , Antígenos CD5 , Conducto Auditivo Externo , Neoplasias del Oído/patología , Linfoma de Células B Grandes Difuso/patología , Hueso Temporal , Anciano , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales de Origen Murino , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Linfocitos B/patología , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/inmunología , Ciclofosfamida/administración & dosificación , Neoplasias del Oído/tratamiento farmacológico , Neoplasias del Oído/inmunología , Epirrubicina/administración & dosificación , Femenino , Humanos , Linfoma de Células B Grandes Difuso/tratamiento farmacológico , Linfoma de Células B Grandes Difuso/inmunología , Prednisona/administración & dosificación , Rituximab , Vincristina/administración & dosificaciónAsunto(s)
Neoplasias del Oído/cirugía , Microcirugia/instrumentación , Neuroma Acústico/cirugía , Radiocirugia/instrumentación , Adulto , Hemorragia Cerebral/epidemiología , Sordera/epidemiología , Neoplasias del Oído/genética , Neoplasias del Oído/inmunología , Nervio Facial/fisiopatología , Parálisis Facial/epidemiología , Parálisis Facial/fisiopatología , Femenino , Genes de la Neurofibromatosis 2/fisiología , Pérdida Auditiva Bilateral/epidemiología , Pérdida Auditiva Sensorineural/epidemiología , Humanos , Antígeno Ki-67/inmunología , Masculino , Estadificación de Neoplasias , Neuroma Acústico/genética , Neuroma Acústico/inmunología , Antígeno Nuclear de Célula en Proliferación/inmunologíaRESUMEN
HYPOTHESIS: Absent or reduced expression of schwannomin/merlin is associated with tumorigenesis of sporadic schwannomas. BACKGROUND: The neurofibromatosis type 2 (NF2) gene frequently is mutated in sporadic vestibular schwannomas. The protein product of the NF2 gene is called schwannomin or merlin. Little is known about the mutated forms of schwannomin/merlin present in schwannomas. METHODS: To investigate further the role of schwannomin/merlin in schwannoma tumorigenesis, immunoblotting experiments were performed. Antischwannomin/merlin-specific antibody that recognizes amino terminus of the protein was used to determine the expression levels of schwannomin/merlin in 16 sporadic vestibular schwannomas, 1 NF2-related vestibular schwannoma, and 5 spinal schwannomas. RESULTS: The antibody detects a protein of approximately 66 kDa in the Triton X-100-insoluble fraction of tumors. The expression of schwannomin/merlin was severely reduced, <35% of control, in 11 (50%) of 22 sporadic schwannomas and in 1 NF2-related vestibular schwannoma. The intensity of 66-kDa schwannomin/merlin band was moderately reduced, from 35-60%, in 7 (32%) of 22 schwannomas compared to the expression levels found in the human brain. Truncated forms of schwannomin/merlin were identified in three tumors with moderately reduced schwannomin/merlin. CONCLUSIONS: These results provide new evidence that inactivation of schwannomin/merlin is an important factor in tumorigenesis of sporadic schwannomas.
Asunto(s)
Neoplasias del Oído/inmunología , Immunoblotting/métodos , Neurilemoma/inmunología , Adulto , Anciano , Niño , Técnicas de Cultivo , Neoplasias del Oído/complicaciones , Femenino , Humanos , Inmunoglobulina G/inmunología , Masculino , Persona de Mediana Edad , Neurilemoma/complicaciones , Neurofibromatosis 2/complicaciones , Neurofibromatosis 2/diagnósticoRESUMEN
BACKGROUND: The aim of the present study was to morphologically characterize the structure of the subepithelial blood vessels in the dark cell area of the human vestibular organs, and to determine whether immunocompetent cells such as macrophages and lymphocytes could be found around these small blood vessels. MATERIALS AND METHODS: All 31 surgical specimens (semicircular canals and utricles) were obtained from patients with vestibular schwannoma. Formalin fixed specimens were stained with hematoxylin and eosin (H&E), and with antibodies to von Willebrand Factor (vWF), leukocyte common antigen (LCA), and UCHL-1, and were examined with light microscope. Specimens fixed with glutaraldehyde were examined with a transmission electron microscope (TEM). OBJECTIVES: Subepithelial blood vessels stained positive for vWF. By TEM observation, these blood vessels were observed to be capillaries that consisted of non-fenestrated endothelium, occasional pericytes, and a basement membrane. They were usually accompanied by melanophages with a number of secondary lysosomes containing phagocytosed degraded melanosomes and lipid droplets. Moreover, melanocytes and their cell processes directly surrounded these subepithelial capillaries. The fact that cells which were positively stained with LCA and UCHL-1 were present both in the intra- and subepithelial layer of the specimens, and that by TEM the intra- and subepithelial mononuclear cells with a lymphoid appearance had clustered dense bodies in their cytoplasm, suggested that they were a population of T lymphocytes. CONCLUSIONS: Results suggested the possibility of a T lymphocyte-melanophage (macrophage) interaction, both originating from and harbored around subepithelial capillaries, which suggests the presence of an immune surveillance system in the human vestibular organs.
Asunto(s)
Vigilancia Inmunológica , Macrófagos/inmunología , Linfocitos T/inmunología , Vestíbulo del Laberinto/irrigación sanguínea , Adulto , Anciano , Capilares/inmunología , Capilares/ultraestructura , Neoplasias del Oído/irrigación sanguínea , Neoplasias del Oído/inmunología , Neoplasias del Oído/patología , Epitelio/irrigación sanguínea , Epitelio/inmunología , Epitelio/ultraestructura , Femenino , Humanos , Inmunohistoquímica , Antígenos Comunes de Leucocito/análisis , Masculino , Persona de Mediana Edad , Neurilemoma/irrigación sanguínea , Neurilemoma/inmunología , Neurilemoma/patología , Canales Semicirculares/citología , Vestíbulo del Laberinto/citología , Vestíbulo del Laberinto/inmunología , Factor de von Willebrand/análisisRESUMEN
Malignant neoplasms of the external ear are difficult diseases of the cervical-facial area to study clinically and therapeutically. The most frequent malignant histological patterns are spinocellular and basocellular carcinomas. Melanomas, basosquamous or "metatypical" carcinomas are less frequent. The latter have a transition histological pattern halfway between a basocellular and spinocellular carcinoma. In our experience, some external ear neoplasms, diagnosed as basocellular, were clinically more invasive (aggressive). Therefore we studied the immunohistochemistry of operative specimens with monoclonal antibodies (MoAb) with the purpose of revaluating the diagnosis after follow-up, and of detecting unrecognized basosquamous carcinomas. We studied 4 patients (2 male and 2 female) aged between 58 and 78, examined in the period 1990-92 an a diagnosed as having an external ear basocellular carcinoma. The immunohistochemical study was carried out using anti-CEA (carcinoembryonal antigen) monoclonal antibodies, high molecular weight acid anticytokeratins (anti-AE3) and low molecular weight basic anticytokeratins (anti-AE1). Appendage origin of the neoplasms was excluded after carrying out MoAb anti-CEA tests, negative in all patients. Epithelial origin of the neoplasms were confirmed after carrying out MoAb anti-AE3 tests, positive in all patients. After carrying out MoAb anti-AE1 tests, positive in 3 patients out of 4, we reviewed the classification of 2 basocellular carcinomas out of 4. These tumors evidenced an atypical dyskeratosis and a positivity for intracellular keratinization. These aspects were not evidenced in the previous histological examinations using routine stains and could be an index of unfavourable clinical evolution of these two cases from a basocellular carcinoma toward a more aggressive basosquamous carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Carcinoma Basocelular/inmunología , Carcinoma Basocelular/patología , Carcinoma Basoescamoso/inmunología , Carcinoma Basoescamoso/patología , Neoplasias del Oído/inmunología , Neoplasias del Oído/patología , Oído Externo/inmunología , Oído Externo/patología , Anciano , Anticuerpos Monoclonales , Carcinoma Basocelular/diagnóstico , Carcinoma Basoescamoso/diagnóstico , Neoplasias del Oído/diagnóstico , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana EdadAsunto(s)
Dermatitis por Contacto/inmunología , Neoplasias del Oído/inmunología , Oído Externo , Oro/efectos adversos , Leucemia Linfocítica Crónica de Células B/inmunología , Neoplasias Cutáneas/inmunología , Adulto , Femenino , Humanos , Hipersensibilidad Tardía/complicaciones , Factores de TiempoRESUMEN
Case of ceruminal adenocarcinoma is reported. Tumor was diagnosed in advance stage, and within a month following diagnosis it caused death. Tumor started from right auditory canal, undermined the pyramidal bone and infiltrated great part of right side of base of skull, narrowing great foramen to a certain extent. Metastasizes were only the right of dura. Besides electron microscopic studies, authors performed the immune-histochemical and lectin-histochemical examination of tumor the first time.
Asunto(s)
Adenocarcinoma/ultraestructura , Neoplasias del Oído/ultraestructura , Adenocarcinoma/inmunología , Cerumen , Neoplasias del Oído/inmunología , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana EdadRESUMEN
4 patients suffering from lymphocytoma had been observed for a mean of 1.75 years (13 to 21 month). The lesions were located on the ears; all patients developed regional lymphadenopathy. Two patients experienced headaches of short duration, one child showed six erythema migrans lesions, and another child had an elevated IgM level of 322 mg/dl. A tick bite was noted in one child. Indirect immunofluorescence tests revealed significantly elevated IgG or IgM antibody titers against Ixodes dammini and Ixodes ricinus spirochetes in all patients. Serological evaluation may be helpful in differentiating borrelial lymphocytoma from other pseudolymphomas.
Asunto(s)
Infecciones por Borrelia/inmunología , Neoplasias del Oído/inmunología , Linfoma no Hodgkin/inmunología , Adulto , Mordeduras y Picaduras/complicaciones , Borrelia/inmunología , Niño , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Inmunoglobulinas/metabolismo , Masculino , GarrapatasRESUMEN
The immunologic explosion has now reached the field of otology. By having better techniques to measure the changes at cellular and molecular levels, it is now possible to devise experiments to show morphologic anatomic changes as well as functional changes. The demonstration in 1980 (M.S.) that tympanosclerosis could be induced immunologically represents a concrete advancement in immunologic thinking in conceptualization of otologic disease. In 1974, one of the authors (M.S.) published work dealing with the treatment of vasculitis of immunologic origin for sudden hearing loss. This was aimed at inhibiting the complement cascade from starting its destructive action. Recently, the immunologic challenge in animals demonstrated by changes in the inner ear was shown by one of the authors (T.J.Y.). Such changes were compatible with labyrinthine hydrops, or Meniere's disease, otosclerosis, and sensorineural hearing loss and vestibular dysfunction.
Asunto(s)
Enfermedades del Oído/inmunología , Oído Medio/inmunología , Colesteatoma/inmunología , Infecciones por Citomegalovirus/inmunología , Sordera/inmunología , Enfermedades del Oído/microbiología , Neoplasias del Oído/inmunología , Pérdida Auditiva Bilateral/inmunología , Humanos , Enfermedad de Meniere/inmunología , Otitis Externa/inmunología , Otosclerosis/inmunología , Membrana Timpánica/inmunologíaAsunto(s)
Comunicación Celular , Ganglios Linfáticos/citología , Linfocitos T/inmunología , Animales , Diferenciación Celular , Movimiento Celular , Colesteatoma/inmunología , Colesteatoma/patología , Neoplasias del Oído/inmunología , Neoplasias del Oído/patología , Femenino , Genes MHC Clase II , Humanos , Células de Langerhans/citología , Células de Langerhans/inmunología , Células de Langerhans/patología , Ganglios Linfáticos/inmunología , Ganglios Linfáticos/fisiología , Linfoma/ultraestructura , Embarazo , Conejos , Quimera por Radiación , Timo/citología , Membrana Timpánica/citología , Membrana Timpánica/embriologíaRESUMEN
Repeated serum IgE determinations in 292 tumour patients, in parallel with clinical check-ups, show the great diagnostic significance of the serum IgE level. The IgE titre variations give an insight into the tumour-host relationship and, in particular, into the current state of activity of the tumour patients who were found to be tumour-free after specific therapy have constant serum IgE values on repeated examination. The serum IgE level declines significantly during radiotherapy and after operative therapy. Tumour recurrence or metastases cause a sharp increase in the serum IgE level already before clinical manifestations can be ascertained. Hence, this method contributes through continued immunological checks towards an early diagnosis of tumour activity.